Caelus Health

Caelus Health is an Amsterdam-based biotechnology company dedicated to developing novel microbiome therapies to reduce insulin resistance in patients with metabolic syndrome and prevent type 2 diabetes (T2DM). The company focuses on commercializing functional food and pharmaceutical products for the prevention and early treatment of cardiometabolic diseases — based on the strong connection between the gut microbiome and health.Building on the expertise of leading scientists in this field, Caelus Health is one of the few companies capable of effectively harnessing the value of microbiome therapeutics through robust preclinical and early clinical development approaches.